Advertisement

Loading...

Cordlife Group Limited

P8A.SISES
Healthcare
Medical - Diagnostics & Research
S$0.14
S$-0.00(-2.11%)
Singapore Market is Open • 14:31

Cordlife Group Limited Fundamental Analysis

Cordlife Group Limited (P8A.SI) shows weak financial fundamentals with a PE ratio of -4.21, profit margin of -29.53%, and ROE of -8.35%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Operating Margin24.26%
Cash Position146.21%
PEG Ratio-0.17
Current Ratio3.13

Areas of Concern

ROE-8.35%
We analyze P8A.SI's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -0.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-0.8/100

We analyze P8A.SI's fundamental strength across five key dimensions:

Efficiency Score

Weak

P8A.SI struggles to generate sufficient returns from assets.

ROA > 10%
-4.08%

Valuation Score

Excellent

P8A.SI trades at attractive valuation levels.

PE < 25
-4.21
PEG Ratio < 2
-0.17

Growth Score

Weak

P8A.SI faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

P8A.SI maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
3.13

Profitability Score

Weak

P8A.SI struggles to sustain strong margins.

ROE > 15%
-835.10%
Net Margin ≥ 15%
-29.53%
Positive Free Cash Flow
No

Key Financial Metrics

Is P8A.SI Expensive or Cheap?

P/E Ratio

P8A.SI trades at -4.21 times earnings. This suggests potential undervaluation.

-4.21

PEG Ratio

When adjusting for growth, P8A.SI's PEG of -0.17 indicates potential undervaluation.

-0.17

Price to Book

The market values Cordlife Group Limited at 0.32 times its book value. This may indicate undervaluation.

0.32

EV/EBITDA

Enterprise value stands at -5.62 times EBITDA. This is generally considered low.

-5.62

How Well Does P8A.SI Make Money?

Net Profit Margin

For every $100 in sales, Cordlife Group Limited keeps $-29.53 as profit after all expenses.

-29.53%

Operating Margin

Core operations generate 24.26 in profit for every $100 in revenue, before interest and taxes.

24.26%

ROE

Management delivers $-8.35 in profit for every $100 of shareholder equity.

-8.35%

ROA

Cordlife Group Limited generates $-4.08 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.08%

Following the Money - Real Cash Generation

Operating Cash Flow

Cordlife Group Limited generates limited operating cash flow of $-4.59M, signaling weaker underlying cash strength.

$-4.59M

Free Cash Flow

Cordlife Group Limited generates weak or negative free cash flow of $-7.40M, restricting financial flexibility.

$-7.40M

FCF Per Share

Each share generates $-0.03 in free cash annually.

$-0.03

FCF Yield

P8A.SI converts -20.74% of its market value into free cash.

-20.74%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-4.21

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.17

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.32

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.24

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.010

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.13

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.08

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

0.04

vs 25 benchmark

How P8A.SI Stacks Against Its Sector Peers

MetricP8A.SI ValueSector AveragePerformance
P/E Ratio-4.2128.31 Better (Cheaper)
ROE-8.35%699.00% Weak
Net Margin-29.53%-130884.00% (disorted) Weak
Debt/Equity0.010.34 Strong (Low Leverage)
Current Ratio3.132775.16 Strong Liquidity
ROA-4.08%-14469.00% (disorted) Weak

P8A.SI outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cordlife Group Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ